Agents iRNA ciblant VEGF

• 收藏
• 分享

专利权人:

Alnylam Pharmaceuticals Inc.

发明人:

申请号：

EP14197031.9

公开号：

EP2899278A1

申请日:

2005.03.11

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The features of the present invention relate to compounds, compositions and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by the mechanism of RNA interference (RNAi). The compounds and compositions include iRNA agents that can be unmodified or chemically-modified.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/